XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Earnings
Noncontrolling Interest
Total
Beginning balance at Dec. 29, 2018 $ 60,884 $ 178,540 $ 839,917 $ (5,938) $ 15,281 $ 1,088,684
Increase (Decrease) in Stockholders' Equity            
Net earnings     35,540   462 36,002
Foreign currency translation adjustment       982 224 1,206
Unrealized gain (loss) on investment & foreign currency       167   167
Distributions to noncontrolling interest         (500) (500)
Issuance of shares under employee stock purchase plans 10 251       261
Net issuance (forfeiture) of shares under stock grant programs 320 6,101       6,421
Issuance of shares under deferred compensation plans 138 (138)        
Expense associated with share-based compensation arrangements   1,226       1,226
Accrued expense under deferred compensation plans   4,899       4,899
Ending balance at Mar. 30, 2019 61,352 190,879 875,457 (4,789) 15,467 1,138,366
Beginning balance at Dec. 29, 2018 60,884 178,540 839,917 (5,938) 15,281 1,088,684
Increase (Decrease) in Stockholders' Equity            
Net earnings           143,728
Ending balance at Sep. 28, 2019 61,390 189,820 969,564 (5,315) 13,644 1,229,103
Beginning balance at Mar. 30, 2019 61,352 190,879 875,457 (4,789) 15,467 1,138,366
Increase (Decrease) in Stockholders' Equity            
Net earnings     54,515   630 55,145
Foreign currency translation adjustment       151 161 312
Unrealized gain (loss) on investment & foreign currency       159   159
Distributions to noncontrolling interest         (400) (400)
Cash dividends     (12,271)     (12,271)
Issuance of shares under employee stock purchase plans 9 272       281
Net issuance (forfeiture) of shares under stock grant programs (11) (262) 3     (270)
Issuance of shares under deferred compensation plans 17 (17)        
Expense associated with share-based compensation arrangements   885       885
Accrued expense under deferred compensation plans   1,026       1,026
Ending balance at Jun. 29, 2019 61,367 192,783 917,704 (4,479) 15,858 1,183,233
Increase (Decrease) in Stockholders' Equity            
Net earnings     51,859   722 52,581
Foreign currency translation adjustment       (963) (364) (1,327)
Unrealized gain (loss) on investment & foreign currency       127   127
Distributions to noncontrolling interest         (734) (734)
Additional purchases of noncontrolling interest   (5,015)     (1,838) (6,853)
Cash dividends     1     1
Issuance of shares under employee stock purchase plans 8 262       270
Net issuance (forfeiture) of shares under stock grant programs 1 (73)       (72)
Issuance of shares under deferred compensation plans 14 (14)        
Expense associated with share-based compensation arrangements   857       857
Accrued expense under deferred compensation plans   1,020       1,020
Ending balance at Sep. 28, 2019 61,390 189,820 969,564 (5,315) 13,644 1,229,103
Beginning balance at Dec. 28, 2019 61,409 192,173 995,022 (4,889) 14,018 1,257,733
Increase (Decrease) in Stockholders' Equity            
Net earnings     40,159   411 40,570
Foreign currency translation adjustment       (5,951) (2,335) (8,286)
Unrealized loss on debt securities       (270)   (270)
Distributions to noncontrolling interest         (299) (299)
Additional purchases of noncontrolling interest   130     (225) (95)
Cash dividends     (7,730)     (7,730)
Issuance of shares under employee stock purchase plans 10 309       319
Net issuance (forfeiture) of shares under stock grant programs 350 12,454 1     12,805
Issuance of shares under deferred compensation plans 89 (89)        
Repurchase of shares (756)   (28,456)     (29,212)
Expense associated with share-based compensation arrangements   1,404       1,404
Accrued expense under deferred compensation plans   5,343       5,343
Ending balance at Mar. 28, 2020 61,102 211,724 998,996 (11,110) 11,570 1,272,282
Beginning balance at Dec. 28, 2019 61,409 192,173 995,022 (4,889) 14,018 1,257,733
Increase (Decrease) in Stockholders' Equity            
Net earnings           189,125
Ending balance at Sep. 26, 2020 61,187 216,002 1,127,375 (6,974) 16,214 1,413,804
Beginning balance at Mar. 28, 2020 61,102 211,724 998,996 (11,110) 11,570 1,272,282
Increase (Decrease) in Stockholders' Equity            
Net earnings     66,463   3,231 69,694
Foreign currency translation adjustment       2,026 125 2,151
Unrealized loss on debt securities       688   688
Cash dividends     (7,644)     (7,644)
Issuance of shares under employee stock purchase plans 10 367       377
Net issuance (forfeiture) of shares under stock grant programs 43 (174) 2     (129)
Issuance of shares under deferred compensation plans 14 (14)        
Expense associated with share-based compensation arrangements   824       824
Accrued expense under deferred compensation plans   1,082       1,082
Ending balance at Jun. 27, 2020 61,169 213,809 1,057,817 (8,396) 14,926 1,339,325
Increase (Decrease) in Stockholders' Equity            
Net earnings     77,204   1,657 78,861
Foreign currency translation adjustment       1,319 265 1,584
Unrealized loss on debt securities       103   103
Distributions to noncontrolling interest         (634) (634)
Cash dividends     (7,646)     (7,646)
Issuance of shares under employee stock purchase plans 7 338       345
Net issuance (forfeiture) of shares under stock grant programs (1) (56)       (57)
Issuance of shares under deferred compensation plans 12 (12)        
Expense associated with share-based compensation arrangements   826       826
Accrued expense under deferred compensation plans   1,097       1,097
Ending balance at Sep. 26, 2020 $ 61,187 $ 216,002 $ 1,127,375 $ (6,974) $ 16,214 $ 1,413,804